PharmacovigilanceOfficial

ANSM lifts pharmacist blister checks for Arrow lenalidomide but keeps handling precautions

🇫🇷 ANSM · Thu 19 Nov 2026

After Arrow introduced visual control of every blister, France's regulator says pharmacists no longer need to inspect lenalidomide packs, while glove and pregnancy-exposure rules still apply.

ANSM updated its notice on a lenalidomide quality defect on 19 November 2026. Arrow has put in place corrective measures that include visual inspection of each lenalidomide blister, so pharmacists are no longer required to check blisters systematically. They may dispense boxes to patients without opening them first.

Subscribe to keep reading

$4.99 / month

  • Every article, analysis and opinion piece on VigiEye and CompePharma
  • One subscription for both sites, cancel any time
Continue with Google
or
You'll be signed in straight away; we also email you a link to confirm your address. Reading every article takes a $4.99/month subscription (secure checkout by Stripe), billed monthly until you cancel; access starts at once, so the 14-day withdrawal right ends when it does. See our terms and privacy policy.

Official source: ANSM ↗

Article written by VigiEye from the official source (ANSM). AI-assisted; check the source before acting.